1. No category

2015 Scientific Poster Session
Platform Presentations
Monday, April 20 – Meeting Rooms 5-6 - 2:00-4:30 p.m.
Innovative
Practices
Therapeutic Case Report
Original Research
Research Trainee
2:00-2:15 p.m.
Melissa Brewster
2:30-2:45 p.m.
Nicole East
3:15-3:30 p.m.
Kyle Burghardt
3:45-4:00 p.m.
Elizabeth Baltenberger
2:15-2:30 p.m.
O. Greg Deardorff
2:45-3:00 p.m.
Ian McGrane
3:30-3:45 p.m.
Ian McGrane
4:00-4:15 p.m.
Katherine Blissit
4:15-4:30 p.m.
Lindsey Peters
Award Finalist Directory
Poster
Number
1
Presenting Author
Baltenberger, Elizabeth
2
Blissit, Katherine
3
Brewster, Melissa
4
5
Burghardt, Kyle
Deardorff, O. Greg
6
7
8
East, Nicole
McGrane, Ian
McGrane, Ian
9
Peters, Lindsey
Title
Evaluation of Pharmacogenomic Testing of Patients with Treatment Resistant
Depression and Schizophrenia within a VA Population
Safety of Benzodiazepine Use Among Four Patient Groups with Post-Traumatic
Stress Disorder (PTSD) in a VA Medical Center
Development and Implementation of a Pharmacist-Managed Intranasal
Naloxone Distribution Program in a Veterans Affairs (VA) Healthcare Facility
and Associated Community Clinics
The Pharmacoepigenetics of Metabolic Syndrome in Schizophrenia
Hematological Clozapine Monitoring with Finger Prick in a Forensic Inpatient
Psychiatric Hospital Setting
Topiramate in the Treatment of Prader-Willi Syndrome
Donepezil-Related Intractable Hiccups: A Case Report
Pharmacogenetics of Cytochrome P450 Enzymes in American Indian and
Caucasian Children Admitted to a Psychiatric Hospital
Therapeutic Effects of Intranasal Insulin Aspart on Cognitive Function in Postoperative Delirium
Scientific Poster Session 1 Directory: Research Trainees
Poster
Number
10
Presenting Author
Abstract Title
Al-Shatnawi, Samah
11
Backe, Kristen
12
Bacon, Opal
13
Banker, Kelly
14
Barnes, Brittany
15
Bauer, Rachel
16
Blaze, Maria
17
Brodrick, Joy
18
19
Brown, Hillary
Brunet, Nicole
20
Buche, Kathryn
21
22
Burke, Amber
Bury, Michelle
23
Campbell, Katelin
24
Campbell, Rebecca
25
Campbell, Wesley
26
Carr, Chelsea
27
Charlestham, David
28
Chen, Dongjia (Val)
29
Christy, Kari
30
Clevlen, Hillarie
31
32
33
Crispo, Angela
Davis, Erica
Dilich, Adam
34
Dimitrievski, Gabriela
35
East, Nicole
36
Eberly, Mary
Influence of Sociological Factors on Physicians Prescribing of Psycho-stimulants
in Adults with Attention Deficit Hyperactivity Disorder
Evaluating the Admission Medication Reconciliation Process in a Behavioral
Health Hospital Setting for Quality Improvement Opportunities
Evaluating Nursing Satisfaction and Utilization of the Clinical Institute
Withdrawal Assessment for Alcohol, Revised Version (CIWA-Ar)
Justifying the Implementation of a Collaborative Drug Therapy Management
(CDTM) Protocol in an Outpatient Psychiatric Clinic: A Retrospective Chart
Review
A Comparison of Patients Taking Multiple Antipsychotics to the VA National
Pharmacy Benefits Management guidelines for Selection of Antipsychotics
Furosemide as an Unintended Masking Agent and Confounder During Chronic
Medication Assisted Treatment for Opioid Use Disorder
Evaluation of Medication Education on 30 day Readmission Rates in Patient with
Psychiatric Disorders
Antidepressant Exposure and Risk of Dementia in Older Adults with Major
Depressive Disorder
Characterization of Benzodiazepines for the Treatment of Catatonia
A Pilot Study of the Rate of Venous Thromboembolism (VTE) in Veterans
Prescribed Aripiprazole vs. Risperidone
The Effect of Targeted Educational Interventions on Mental Health Prescriber
Knowledge and Opinions Concerning Chronic Benzodiazepine Use
Antipsychotic Polypharmacy and Prescribing Habits After Policy Implementation
Impact of a Mental Health Clinical Pharmacist on a Primary Care Mental Health
Integration Team
Reducing Costs of Aripiprazole Utilization Through a Single Targeted
Intervention
A Retrospective Chart Review of the Prescribing Patterns of First-and SecondGeneration Antipsychotics in an Adult Inpatient Psychiatric Population
Design and Implementation of a Psychiatric Pharmacy and Psychology
Collaborative Intervention for Management of Comorbid Depression and
Diabetes Mellitus
Evaluation of Adherence in Patients Prescribed Long-Acting Injectable
Antipsychotics: A Comparison of Bi-Weekly versus Monthly Administered
Neuroleptics
Prescribing Patterns for Outpatient Oral Antipsychotics: Focus on High-Dose
Prescribing and Antipsychotic Polypharmacy
GABA-A Receptor Model with Gamma-Aminobutyric Acid and Benzodiazepine
Binding Sites
Exploratory Analysis of Clozapine Prescribing Barriers and Utilization at the
Cincinnati Veteran Affairs Medical Center
Buprenorphine Utilization and Patient Outcomes Post-Implementation of an
Opioid Detoxification Protocol
Evaluation of Psychotropic Medication Adherence in a Correctional Facility
Clozapine Treatment in Patients with Benign Neutropenia
Dementia in an Aging Veteran Population: The Impact of Established Criteria for
Use on Memantine Prescribing Patterns
Evaluation of Opioid and Benzodiazepine Prescription and use in the Indiana
Medicaid Child and Adolescent Population
Ziprasidone Use in a Youth Inpatient Psychiatric Population: A Retrospective
Chart Review
Impact of Pharmacist-conducted Psychotropic Medication Reviews on
Appropriate Prescribing Patterns within a Veterans Affairs Medical Center
Scientific Poster Session 1 Directory: Research Trainees
Poster
Number
37
Presenting Author
Abstract Title
El-Amin, Brooke
38
39
Fantino, Cristina
Fantino, Cristina
40
Finocchio, Brittany
41
Fischer, Matthew
42
Franck, Hugh
43
Gardner, Kristen
44
Girgis, Sandra
45
Givens, Courtney
46
Gomez, Seth
47
Gower, Jeffrey
48
Gross, Tonya
49
Hawthorne, Jessica
50
51
52
Hofammann, Elizabeth
Jackson, Elizabeth
Jackson, Elizabeth
53
Johnson, Efe
54
Johnson, Eric
55
Johnson, Joseph
56
57
Jubran, Nadia
Kaigle, Allie
58
Kay, Lehua
59
60
Kim, Estelle
Koller, Katherine
61
Koyle, Megan
62
Kubascik, Erica
63
Lad, Raina
64
Leach, Molly
Comparison of Adherence to Antiretroviral Medications Among Persons with
Mental Health Disorders in a Veteran Patient Population
Antipsychotic Polypharmacy: Is Three Too Many?
Evaluation of Cannabis Use in Veterans with Posttraumatic Stress Disorder at
VA Connecticut Healthcare System
Relationship Between Aggression Scores and Emergent Medication Use on a
Pediatric Inpatient Psychiatry Unit
Prolongation of the QTc Interval with Use of Injectable Haloperidol in a
Community Hospital
Development of a Clinical Psychiatric Pharmacy Consultation Service within a
Veterans Health System
Cost Avoidance and Qualitative Analysis of Clinical Pharmacy Interventions by
Psychiatry Pharmacy Residents at State Psychiatric Facilities
Evaluation of the Use of Electrocardiogram Monitoring in Patients on
Psychotropic Medications that Have a Risk of QT Prolongation
The Effects of Antidepressants in Veterans with Alcohol Use Disorder and
Comorbid Depression
An Evaluation of Antipsychotic Selection and Time to Repeat Use in the
Psychiatric Emergency Department
Veteran Interest in Benzodiazepine Discontinuation After Receiving a Direct-toPatient Educational Brochure
Evaluating the Effect of Interventions on Readmission Rates in Patients with
Chemical Dependency Admitted on Inappropriate Medications
Does Primary Care Clinic Co-location and Integration in a Mental Health Setting
for Veterans with Serious Mental Illness Improve Medication Adherence?-A
Pilot Study
Antipsychotic Polypharmacy Prescribing Patterns Across a Large Health-system
Aspiration Pneumonia Potentially Related to Clozapine-Induced Sialorrhea
Impact of Psychiatric Pharmacists on Target Symptoms in Veterans with Mental
Health Conditions
Realized Cost Savings From Implementation of a Bulk Medication Recycling
Program
Comparison of Abnormal Involuntary Movements in Patients Receiving
Clozapine Monotherapy Vs. Patients Receiving Clozapine Plus a Typical
Antipsychotic
The Effects of Cannabis on Inpatient Agitation, Aggression, and Length-of-Stay
in Patients with Schizophrenia, Schizoaffective Disorder, and Bipolar Disorder
Economic Impact of Pharmacist Services in the Community Setting
Evaluation of Prescription Trends in Patients with Post-traumatic Stress Disorder
(PTSD) at a Veterans Affairs Healthcare Center
PRN Medication Use at a State Hospital: Impact of Converting Psychotropic
PRN Orders From a Duration of 24 hours to 72 hours
The Effects of Lamotrigine in Bulimia Nervosa
QA/QI Project to Assess Pharmacologic Therapy for Treatment of Alcohol Use
Disorder in the Outpatient Setting at VA Western NY Healthcare System
A Retrospective Evaluation of Concomitant use and Outcomes Related to use of
Prazosin with Other Alpha-1 Antagonists
Evaluation of Long-acting Injectable (LAI) Antipsychotics in Children and
Adolescents within Indiana Medicaid
Second Generation Antipsychotic Prescribing Patterns in an Inpatient Acute Care
Psychiatric Setting
Implementation and Evaluation of a Combined Mental Health and PostTraumatic Stress Disorder Treatment Clinic Via Clinical Video Telehealth
Scientific Poster Session 1 Directory: Research Trainees
Poster
Number
65
Presenting Author
Abstract Title
Lettmann, Shelly
66
Lian, Nadia
67
68
Lister, Jonathan
Mabus, Casey
69
Mathis, Erin
70
Mauda , Tatiana
71
72
May, Meghan
McCormack, Zack
73
McGraw, Dan
74
Moreno, Jessica
75
Oji, Chinelo
76
Ouyang, Shuang
77
Pan, Isaac
78
Parra, Brianne
79
Perry, Sarah
80
Perry, Sarah
81
Preinitz, Jennifer
82
83
Qureshi, Imran
Roestenburg, Sadie
84
85
Sams, Amy
Sams, Amy
86
Schmidt, Robert
87
Sciurba, Anne
88
Seratt, Kimberly
89
Sevak, Rajkumar
90
Shell, Megan
Role of Psychiatric Pharmacists in Improving Transitions of Care for Patients
Recently Discharged from a Psychiatric Institution to an Outpatient Setting
A Medication Use Evaluation (MUE) for the Treatment of Tourette’s Syndrome
(TS)
A Case of Nonfatal Torsades de Pointes Associated with Polypharmacy
Use of Prescription Stimulants Among Students in Doctor of Pharmacy Training
Programs
Evaluation of Naloxone Rescue Kit Education and Distribution Initiative at a VA
Medical Center
A Retrospective Chart Review of Counseling Female Veterans of Childbearing
Age About the Risk of Birth Defects Prior To the Initiation of Potentially
Teratogenic Psychiatric Medications
Assessment of Factors Leading to 30-Day Psychiatric Readmissions
The Perception of Mental Illness Among the Public, Pharmacists, and Other
Medical Professionals
Effect of a Symptom-Driven Opioid Withdrawal Scale on Clonidine Provision
and Hypotension Risk
Evaluating the Therapeutic Milieu in an Inpatient Acute Psychiatry Unit from the
Patient Perspective
A Pharmacist-led Approach to Increasing Clozapine Utilization at the South
Texas Veterans Healthcare System: A Continuous Quality Improvement Project
Use of Clonidine in a Patient Intolerant to Prazosin for Post-traumatic Stress
Disorder Nightmares: A Case Report
A Retrospective Evaluation of Clozapine Utilization and Risk of ClozapineInduced Neutropenia in an Inpatient Psychiatric Setting
Cognitive Behavioral Therapy for Insomnia: Inclusion of Pharmacist Education
and Interventions in Zolpidem Dependent Veterans
Development of an Emergency Department Protocol for the Evaluation and
Management of Patients at Risk for Alcohol Withdrawal
Ziprasidone Induced Neutropenia in a Patient Previously Stable on Clozapine
Therapy
Comparative Efficacy of Bupropion, Venlafaxine, and Sertraline in Treatment of
PTSD in OEF/OIF/OND Veterans
Use of Gabapentin for Management of Alcohol Withdrawal Syndrome Inpatients
Clinical Outcomes of Veterans with Serious Mental Illnesses Enrolled in a
Pharmacist-Managed Metabolic Monitoring Clinic: A Retrospective Cohort
Study
Antipsychotic Use in Veterans with Parkinson's Disease
Optimizing the Process for Identifying and Initiating Clozapine Therapy in
Eligible Veterans
Utilization and Effectiveness of Antiepileptic Drugs for the Treatment of PostTraumatic Stress Disorder
Impact of Installation of Stimulant Quick Order on Prescribing and Monitoring of
Stimulants in a Veteran Population
The Effect of Paliperidone Palmitate Long-Acting Injection (LAI) versus
Risperidone LAI on Length of Stay and Time to Relapse in Patients with
Schizophrenia and Schizoaffective Disorder Admitted to an Inpatient Psychiatric
Unit
Yearly Trends in Controlled Substances Obtained Via Permanent Drug Donation
Boxes in Northeast Tennessee
Evidence-Based Use of Prophylactic Anticholinergic Medication in Combination
with Antipsychotic Pharmacotherapy in an Acute Inpatient Psychiatric Setting
Scientific Poster Session 1 Directory: Research Trainees
Poster
Number
91
Presenting Author
Abstract Title
Sherman, Matthew
92
Sklansky, Alexandra
93
Slough, Courtney
94
Sordo, Eileen
95
96
97
Spiegel, Aila
Stolz , Brigitte
Stutzman, Danielle
98
Thamawatanakul, Rani
99
100
Thiboutot, Caitlyn
Titus-Lay, Erika
101
Valentino, Natalie
102
Van Dyke, Priscilla
103
Ward, Kayla
104
Weed, Elizabeth
105
Wilkening, G. Lucy
106
Wong, Jason
107
Zoucha, Allysa
Difference in Control of Psychosis and Aggression for Patients Receiving the
Maximum Dose of Haloperidol Decanoate Every Two Weeks Compared to
Every Four Weeks
Evaluation of the Effect of Depression and Antidepressant Use on Time in
Therapeutic Range of INR in Warfarin Treated Patients
The Incidence of Leukopenia, Neutropenia, and Agranulocytosis in Veterans
Receiving Aripiprazole
Quality Assurance and Quality Improvement Review to Determine Performance
of the PTSD Medication Management Clinic in Treating Patients with PostTraumatic Stress Disorder
Impact of the Opioid Safety Initiative at the VA San Diego Healthcare System
Clozapine Levels Rise and Fall with Propranolol: A Case Report
Psychotropic Prescribing Practices and Physician Attitudes on Integrating
Psychiatric Pharmacist Services in an Ambulatory Care Setting
Compliance with Pain Management Guidelines for Chronic Non-Cancer Pain at a
Veteran Affairs Medical Center
Test-taking Anxiety Amongst Nursing and Pharmacy Students
Molly (3,4-methylenedioxy-methamphetamine (MDMA)) Prevalence and use
Patterns Among Students at a Large Public University in West Lafayette, Indiana
Impact of an Educational Intervention on Attitudes and Practices of Mental
Health Staff Toward Smoking Cessation in Patients with Substance Use
Disorders
The Influence of Concomitant Calcium Channel Blocker and Antipsychotic
Treatment on Efficacy Measures in Patients with Schizophrenia
A Comparative Study of Self-Reported Medication Knowledge and Attitudes of
Patients with Psychiatric Disorders with or without Participation in a Patient
Medication Education Group
Pain Management Pharmacotherapy Treatment for Fibromyalgia, Radiculopathy,
or Spinal Stenosis in Veterans with a Co-Occurring Psychiatric Disorder
Compared to Veterans without a Psychiatric Diagnosis
Evaluation of Virtual Patient Technology for Interdisciplinary Education of
Psychiatry Residents
The Impact of Pharmacist Intervention on Hospital-Based Inpatient Psychiatric
Services (HBIPS) Scores at an Academic Medical Center
Efficacy and Tolerability of Long-acting, Injectable Antipsychotics within a
Veteran Population
Scientific Poster Session 2 Directory
Poster
Number
10
Presenting Author
Abstract Title
Barber, Michael
11
Bellnier, Terrance
12
Boggs, Douglas
13
Bostwick, Jolene
14
15
Brahm, Nancy
Brahm, Nancy
16
Brahm, Nancy
17
18
19
Brahm, Nancy
Brahm, Nancy
Brahm, Nancy
20
21
Brahm, Nancy
Brahm, Nancy
22
Brook, Richard
23
Butz, Jami
24
Carstens, Ashley
25
Cates, Marshall
26
Cates, Marshall
27
Chen, Jack
28
Clark, William
29
30
Cunningham, Julie
Curtis, Judy
31
D’Souza, Ian
32
Darvesh, Altaf
33
Delgado, Lizbhet
34
D'Souza, Ian
35
Duffy, Ruth
36
37
Dutton, Traci
Fabrikant, Alla
The Value of Early Improvement as a Predictor of Short-Term Response During
Treatment of Bipolar Depression with Lurasidone
The Potential Role of Aripiprazole Long-Acting Injectable (LAI) for Patients
Diagnosed with DSM-IV Schizophrenia with Comorbid Substance Abuse
Cannabinoid Receptor Antagonist Treatment of Cognitive Dysfunction in
Schizophrenia
A Pharmacist-Led Initiative for Telephone Medication Reconciliation in the
Setting of an Ambulatory Psychiatry Clinic
Aripiprazole Long-Acting Injection-Induced Akathisia
Development of a Peer Community Healthcare Worker for a Community-Based
Youth Services Outreach Program
Engaging Youth in the Design and Delivery of Healthcare: The Community
Health Worker Project
Female Priapism Masquerading as Tactile Hallucinations
Fish Oil Supplementation, Breastfeeding, and Mood Stabilization
Lithium Carbonate in the Treatment of Neurobehavioral Disorders in Two
Children with Fetal Alcohol Spectrum Disorder
Quetiapine-induced Ocular Dyskinesia: A Case Report
The “Treatment” Effect of Illicit Drugs on Anxiety Reduction for Homeless
Individuals Experiencing PTSD
Comparisons of the Health Benefit Costs Among Monotherapy and Adjunctive
Therapy Patients with Epilepsy and Their Employed Spouses
Development of an Electronic Adverse Drug Reaction Surveillance System at a
Psychiatric Hospital
Interprofessional Process Improvement to Optimize Medication Regimens of
Psychiatric Patients
Effects of a Focused Continuing Education Program on Pharmacists’ Attitudes
Toward Suicide Prevention
Pharmacy Students’ Attitudes Toward Mental Illness are Unaffected by
Participation in a Psychiatric Pharmacy Advanced Pharmacy Practice Experience
Systematic Literature Review of AbobotulinumtoxinA in Clinical Trials for
Lower Limb Spasticity
Effects of Lurasidone on Hostility in Patients with an Acute Exacerbation of
Schizophrenia: A Pooled Analysis of Five Short-Term Studies
The Effect of Gastric Bypass on the Pharmacokinetics of Venlafaxine ER
Lurasidone Pharmacokinetics and Safety Profile in Pediatric Patients with
Psychiatric Disorders
Asenapine for the Treatment of Pediatric Manic or Mixed Episode of Bipolar I
Disorder
Clozapine Pharmacotherapy in Treatment Resistant Schizophrenia in an
Acute-Care Psychiatric Setting
Effect of Lurasidone on Metabolic Parameters in Patients with Bipolar
Depression
Post Hoc Analyses of Anxiety Measures in Adult Patients with Generalized
Anxiety Disorder Treated with Vilazodone
Efficacy of Brexpiprazole (OPC-34712) in Acute Schizophrenia: Results of Two
Pooled Pivotal Studies
Improving PTSD Care through Education and Training in a Rural Community
Successful Initiation of Clozapine in Patient with HIV and Hodgkin’s Lymphoma
Scientific Poster Session 2 Directory
Poster
Number
38
Presenting Author
Abstract Title
Frazier, Erica
39
40
41
42
Furmaga, Kevin
Gonzalez, Misty
Grgas, Marina
Griffith, June
43
Harris, Suzanne
44
Hsieh, Andrew
45
Kok Seng, Chee
46
Laird, Lyle
47
48
Leach, Henry
Letts, Victoria
49
50
Leung , Jonathan
Leung, Jonathan
51
Lorenz, Raymond
52
Luciano, Jennifer
53
Mackzum, Adrienne
54
Markowitz, John
55
Maroney, Megan
56
Marvanova, Marketa
57
Marvanova, Marketa
58
McClellan, Ryan
59
McClellan, Ryan
60
61
McGuire, Michael
Moeller, Karen
62
Moore, Tera
63
Muzyk, Andrew
64
Najarian, Dean
65
Nelson, Jennifer
Implementation of an Interprofessional Training Program (ITP) in Primary CareMental Health Integration (PC-MHI): An Update
The Predictive Value of Gene Variants Used To Guide Antidepressant Selection
Surveying Addiction Recovery Resources Available for Pharmacists
Utilizing a Locked Medication Dispenser for Suboxone Patients
Medication use Evaluation to Decrease the Number of Patients who are Taking 3
or More Antidepressants as Part of the VISN 7 Psychopharmacology Plan
Characterization of Medication-Related Factors in a High Utilizer, Adult
Psychiatric Population
A Phase 2b, Randomized, Double-blind, Placebo-controlled, 12-week Study of
Encenicline, an α7 Nicotinic Acetylcholine Receptor Partial Agonist, for
Cognitive Impairment in Patients with Schizophrenia
Pharmacist-run Medication Management Service to Reduce Inappropriate
Benzodiazepine and Anticholinergic Medication Usage over 6 months and 1 year
Efficacy and Safety of Lurasidone in Older Adults with Bipolar Depression:
Analysis of Two Double-blind, Placebo-controlled Studies
Decreasing Transfers to the Emergency Room from a Psychiatric Hospital
Psychiatric Emergency: What Are We Doing? a Retrospective Chart Review of
the Pharmacological Management of Psychiatric Emergencies in an Adolescent
Unit
Necrotizing Deep Tissue Infection Associated with Paliperidone Palmitate
Psychosis or Obsessions? Clozapine Associated with the Worsening Obsessivecompulsive Symptoms
GeneSight Psychotropic Decreases Medication Costs in a Large, Prospective
Case-control Project
Prolonged Psychosis in an Individual with No Psychiatric History Following
Magic Mushroom Ingestion
Pharmacy Practice with Traumatic Brain Injury (TBI) Inpatients in a Specialized
Rehabilitation Hospital
An Ex Vivo Approach To Botanical-Drug Interactions: A Proof of Concept
Study
Psychiatric Pharmacist Involvement in an Integrated Health Home for the
Seriously Mentally Ill
Ability of Community Pharmacists in Rural Areas across the US to Provide
Pharmacy Care for Persons with Alzheimer’s Disease and Dementia
Prescribing Rates of Dopamine Agonists as Monotherapy or Anticholinergics
among Community-Dwelling Persons with Parkinson’s Disease across the United
States
The Efficacy of Vortioxetine in the Treatment of Patients with MDD in ShortTerm Placebo-Controlled Studies: A Meta-Analysis of 11 Studies
The Safety and Tolerability of Vortioxetine in Treating Adults with Major
Depressive Disorder After 52 Weeks of Open-Label Treatment
The Effect of an Elective Psychiatric Course on Pharmacy Student Empathy
Psychotropic Polypharmacy Among Inpatients with Borderline Personality
Disorder
Primary Care Mental Health Integration: Evaluating the Impact of Behavioral
Health Clinical Pharmacy Specialists
Impact of an Alcohol Withdrawal Treatment Pathway on Hospital Length of
Stay: A Retrospective, Single-Center Cohort Study
Efficacy and Safety of Paliperidone Palmitate 3 month Formulation: A
Randomized, Double-blind, Placebo-controlled Study
Treatment of Bulimia Nervos During Pregnancy within a Correctional Healthcare
Setting: A Case Report
Scientific Poster Session 2 Directory
Poster
Number
66
Presenting Author
Abstract Title
Ng-Mak, Daisy
67
Nichols, Stephanie
68
Norton, Merrill
69
Norton, Merrill
70
Nuhi, Veldana
71
Otcheretko, Victor
72
Palmer, Emma
73
Park, Susie
74
Patrick, Pauline
75
76
Popish, Sarah
Price, Scott
77
Reinstatler, Kristina
78
Reinstatler, Kristina
79
Sachdeva, Parshotam
80
Schneiderhan, Mark
81
Smith, Thomas
82
Suansanae, Thanarat
83
Tewksbury, Ashley
(Withdrawn)
84
85
Thomas, Kelan
Tomko, John
86
Vickery, P. Brittany
87
Weiss, Catherine
88
Williams, Andrew
89
Wright, Alan
Patterns of Weight Change Before and After Lurasidone Initiation in Patients
with Serious Mental Illness
Implementation and Impact of Pharmacist Clozapine Consults at a Tertiary Care
Medical Hospital
Perceived Stress and Impulsivity as a Predictor of Substance Use DisordersFindings from the Student Pharmacist Chemical Health Scale III
Student Pharmacists and Alcohol Drinking Behavior: Findings from a
Collaborative of Colleges of Pharmacy in the United States
Concomitant Opioid and Benzodiazepine Interventions in a Veterans Affairs
Mental Health Outpatient Setting
Switching From Memantine Immediate Release (10 mg, Twice Daily) to
Memantine Extended Release (28 mg, Once Daily) for Patients with Moderate to
Severe Alzheimer’s Disease: Pharmacokinetics, Safety, and Tolerability
Evaluation of Perceptions and Knowledge of Mental Illness in the United States
of America Through Crowdsourcing-Where Are We Now?
CYP2D6 Genotyping to Evaluate a Drug Interaction between Antidepressants
and Analgesics
Effects of Levomilnacipran ER on Motivation/Energy and Functional
Impairment in Adults with Major Depressive Disorder: Post Hoc Analysis of a
Phase 3 Trial
Academic Detailing: Promoting Rational Prescribing of Pain Based Modalities
Evaluating the Economic Impact of a Psychiatric Clinical Pharmacist at a
Community Medical Center
Readmission Rates of Psychiatric Patients Who Receive Pharmacist Led
Medication Consultation at Discharge
Readmissions in Patients Treated with Long-acting Injectable Antipsychotics
during an Acute Psychiatric Hospitalization
Optimizing Response to Lurasidone in Patients with Acute Schizophrenia: A
Randomized, Double-Blind, Placebo-Controlled Study of Dosing Regimens
A 12 - Month Randomized Analyses of Pharmacist Comprehensive Medication
Management Services in Community Mental Health
Effective Therapy with Buspirone for Psychiatric Symptoms in Huntington's
Disease
Symptom-Based Pharmacotherapy in Irritability Associated with Autism
Spectrum Disorder Recommended by Psychiatric Pharmacist
Administration of Subanesthetic Dose of Ketamine and Electroconvulsive
Treatment on Alternate Days in Patients with Treatment Resistant Depression: A
Double Blind Placebo Controlled Trial
The Effects of Regular Marijuana Use on Driving Performance
Avoiding Risks: Paliperidone Palmitate IM as a Reasonable Alternative to
Clozapine in Schizophrenia Patients That Relapse to Smoking Following
Hospital Discharge
Early Detection of Neuroleptic Malignant Syndrome Versus Catatonia: A Case
Report
Efficacy and Safety of Adjunctive Brexpiprazole (OPC-34712) in Major
Depressive Disorder: Results of Two Pivotal Clinical Studies
Fill or Don’t Fill? Nonpsychiatric Pharmacists’ Perceptions and Knowledge of
Clozapine Use in an Academic Medical Center
The Effect of Vortioxetine (LU AA21004) on Health-Related Quality of Life
(HRQoL) in Patients with Major Depressive Disorder (MDD)